[1] HEDDLE N M,SOUTAR R L,O'HOSKI P L,et al.A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion[J].Br J Haematol,1995,91(4):1000-1005.
[2] PERRY H,BOVIN N,HENRY S.A standardized kodecyte method to quantify ABO antibodies in undiluted plasma of patients before ABO-incompatible kidney transplantation[J].Transfusion,2019,59(6):2131-2140.
[3] SELTSAM A.Application of recombinant antigens to blood group diagnostics[J].ISBT Sci Ser,2011,6(1):13-16.
[4] SELTSAM A,AGAYLAN A,GRUEGER D,et al.Rapid detection of JMH antibodies with recombinant Sema7A (CD108) protein and the particle gel immunoassay[J].Transfusion,2008,48(6):1151-1155.
[5] YAMAMOTO F,CLAUSEN H,WHITE T,et al.Molecular genetic basis of the histo-blood group ABO system[J].Nature,1990,345(6272):229-233.
[6] MERRIMAN B,R&D TEAM I T,ROTHBERG J M.Progress in Ion Torrent semiconductor chip based sequencing[J].Electrophoresis,2012,33(23):3397-3417.
[7] AMBARDAR S,GUPTA R,TRAKROO D,et al.High throughput sequencing:an overview of sequencing chemistry[J].Indian J Microbiol,2016,56(4):394-404.
[8] VAN DIJK E L,JASZCZYSZYN Y,NAQUIN D,et al.The third revolution in sequencing technology[J].Trends Genet,2018,34(9):666-681.
[9] ARDUI S,AMEUR A,VERMEESCH J R,et al.Single molecule real-time (SMRT) sequencing comes of age:applications and utilities for medical diagnostics[J].Nucleic Acids Res,2018,46(5):2159-2168.
[10] BRANTON D,DEAMER D W,MARZIALI A,et al.The potential and challenges of nanopore sequencing[J].Nat Biotechnol,2008,26(10):1146-1153.
[11] TORMEY C A,STACK G.Immunogenicity of blood group antigens:a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies[J].Blood,2009,114(19):4279-4282.
[12] HALL A M,CAIRNS L S,ALTMANN D M,et al.Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice[J].Blood,2005,105(5):2175-2179.
[13] DARKE C,STREET J,SARGEANT C,et al.HLA-DR antigens and properdin factor B allotypes in responders and non-responders to the Rhesus-D antigen[J].Tissue Antigens,1983,21(4):333-335.
[14] LIN WC, PERNG CL, CHANG JS.HLA-DR associations in individuals with red blood cell antibody anti-E[J].Vox Sang ,2014,107(suppl 1):200.
[15] CHIARONI J,DETTORI I,FERRERA V,et al.HLA-DRB1 polymorphism is associated with Kell immunisation[J].Br J Haematol,2006,132(3):374-378.
[16] NOIZAT-PIRENNE F,TOURNAMILLE C,BIERLING P,et al.Relative immunogenicity of Fya and K antigens in a Caucasian population,based on HLA class II restriction analysis[J].Transfusion,2006,46(8):1328-1333.
[17] RAOS M, ZUNEC R, GROJCETA K, et al.The association of the HLA system polymorphisms with alloimmunization to Fya red blood cell antigens[J].Vox Sang, 2014,107(suppl 1):245.
[18] ANSART-PIRENNE H,ZELISZEWSKI D,LEE K,et al.Identification of immunodominant alloreactive T-cell epitopes on the Jka red blood cell protein inducing either Th1 or Th2 cytokine expression[J].Blood,2004,104(10):3409-3410.
[19] REVIRON D,DETTORI I,FERRERA V,et al.HLA-DRB1 alleles and jk(a) immunization[J].Transfusion,2005,45(6):956-959.
[20] CHU C C,HO H T,LEE H L,et al.Anti-Mi(a) immunization is associated with HLA-DRB1*0901[J].Transfusion,2009,49(3):472-478.
[21] BALEOTTI W Jr,RUIZ M O,FABRON A Jr,et al.HLA-DRB1*07:01 allele is primarily associated with the Diego a alloimmunization in a Brazilian population[J].Transfusion,2014,54(10):2468-2476.
[22] KÖRMÖCZI G F,MAYR W R.Responder individuality in red blood cell alloimmunization[J].Transfus Med Hemother,2014,41(6):446-451.
[23] HANCHARD N A,MOULDS J M,BELMONT J W,et al.A genome-wide screen for large-effect alloimmunization susceptibility loci among red blood cell transfusion recipients with sickle cell disease[J].Transfus Med Hemother,2014,41(6):453-461.
[24] HUDSON K E,LIN E,HENDRICKSON J E,et al.Regulation of primary alloantibody response through antecedent exposure to a microbial T-cell epitope[J].Blood,2010,115(19):3989-3996.
[25] ZIMRING J C,SPITALNIK S L,ROBACK J D,et al.Transfusion-induced autoantibodies and differential immunogenicity of blood group antigens:a novel hypothesis[J].Transfusion,2007,47(12):2189-2196.
[26] HALL A M,CAIRNS L S,ALTMANN D M,et al.Immune responses and tolerance to the RhD blood group protein in HLA-transgenic mice[J].Blood,2005,105(5):2175-2179.
[27] ZIMRING J C,HUDSON K E.Cellular immune responses in red blood cell alloimmunization[J].Hematology Am Soc Hematol Educ Program,2016,2016(1):452-456.
[28] GIRARD-PIERCE K R,STOWELL S R,SMITH N H,et al.Marginal zone B cells mediate alloantibody formation to a clinically significant human RBC antigen in a murine model[J].Blood,2012,120(21):843.
[29] STOWELL S R,GIRARD-PIERCE K R,SMITH N H,et al.Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies[J].Transfusion,2014,54(1):179-189.
[30] CLAAS F H,GIJBELS Y,VAN DER VELDEN-DE MUNCK J,et al.Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life[J].Science,1988,241(4874):1815-1817. |
